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Background: The early life of the human host marks a critically important time for establishment of the gut microbial
community, yet the developmental trajectory of gut community-encoded resistance genes (resistome) is unknown. We
present a longitudinal study of the fecal antibiotic resistome of healthy amoxicillin-exposed and antibiotic-naive twins
and their mothers during the first year of life.
Results: We extracted metagenomic DNA (mgDNA) from fecal samples collected from three healthy twin pairs at three
timepoints (1 or 2 months, 6 or 7 months, and 11 months) and from their mothers (collected at delivery). The mgDNA
was used to construct metagenomic expression libraries in an Escherichia coli host. These libraries were screened for
antibiotic resistance, and functionally selected resistance genes were sequenced and annotated. A diverse fecal
resistome distinct from the maternal resistome was apparent by 2 months of age, and infants’ fecal resistomes
included resistance to clinically important broad-spectrum beta-lactam antibiotics (e.g., piperacillin-tazobactam,
aztreonam, cefepime) not found in their mothers. Dissemination of resistance genes among members of a given
family was positively correlated with sharing of those same resistance genes between unrelated families, potentially
identifying within-family sharing as a marker of resistance genes emerging in the human community at large. Finally,
we found a distinct developmental trajectory for a community-encoded function: chloramphenicol resistance. All study
subjects at all timepoints harbored chloramphenicol resistance determinants, but multidrug efflux pumps (rarely found
in mothers) were the primary effectors of chloramphenicol resistance in young infants. Chloramphenicol acetyltransferases
were more common in mothers than in infants and were found in nearly all the infants at later timepoints.
Conclusions: Our results suggest that healthy 1–2-month-old infants’ gut microbes harbor clinically relevant resistance
genes distinct from those of their mothers, and that family-specific shared environmental factors early in life
shape resistome development.
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resistanceBackground
The human gut microbiota is an important reservoir of
antibiotic resistance genes (resistome), which can be ex-
changed with pathogens [1–4]. Diverse antibiotic resist-
ance genes are present in the gut microbiota of young
infants soon after birth, even without antibiotic therapy* Correspondence: dantas@wustl.edu
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creativecommons.org/publicdomain/zero/1.0/[5–12]. While the overall architecture of the gut micro-
bial community undergoes chaotic shifts in the first
years of life before stabilizing towards an adult-like state
[13–16], the trajectory and dynamics of resistome devel-
opment in healthy young infants are poorly understood.
Children in the United States are heavily antibiotic-
exposed [11, 12], with unclear effects on resistome devel-
opment. In this study, we present a longitudinal functional
metagenomic interrogation of gut resistome development
during the first year of life in three pairs of healthy, vagi-
nally delivered, formula-fed twins enrolled in the St. Louis
Neonatal Microbiome Initiative. One pair was antibiotic-
naïve for the entire sampling interval, one pair wasticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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eously at 8 months of age) and one was discordant (one
sibling received 10 days of amoxicillin at 8 months and
the other did not).
Results
Demographic information regarding the three families
included in this study is listed in Additional file 1: Table
S1. We constructed 21 fecal metagenomic libraries aver-
aging 9.3 ± 7.9 (mean ± s.d.) gigabases (Gb) in size, from
18 infant samples and 3 maternal samples, and used
functional metagenomic selections paired with next-
generation sequencing to identify a total of 905 unique
predicted antibiotic resistance protein clusters (collapsed
at 97 % amino acid identity using cd-hit [17, 18]). In all in-
dividuals, at all timepoints, we identified protein clusters
conferring resistance to five different antibiotic classes (β-
lactams, tetracycline, chloramphenicol, trimethoprim, and
cycloserine). Proteins conferring resistance to aminoglyco-
sides, tigecycline, and colistin were also found, but less fre-
quently. Of the 905 resistance protein clusters identified,
296 (32 %) were unique to mothers, 531 (59 %) were
unique to infants, 142 (15.6 %) were shared between twin
siblings, 159 (17.5 %) persisted within the same individualFig. 1 Twin infant fecal resistomes resemble those of their siblings. Predict
Jaccard resistance protein cluster composition similarity was determined fo
siblings, (3) unrelated infants, and (4) mothers and infants from the same fa
penicillin-binding proteins at right. Significance was calculated using the St
resistomes overall (a) were significantly more similar to a twin sibling or to the
infants. Infant resistomes were no more similar to those of their mothers than
the similarity between infants and their twin sibling and the persistence of res
timepoints (self-sharing)at multiple timepoints, and 106 (11.7 %) were shared be-
tween unrelated infants. Only 51 (5.6 %) were shared be-
tween infants and their mothers. Twin siblings’ resistomes
were significantly more similar to each other than to those
of their mothers or unrelated infants (p < 0.01, Stu-
dent’s t-test with 1000 Monte Carlo simulations, Fig. 1).
Conversely, they were as similar to their siblings’ resis-
tomes as they were to their own at other points in time
and no more similar to their mothers’ resistomes than
to unrelated infants’ resistomes (Fig. 1). There was no
difference in sharing between infants and their own
mothers and infants and unrelated mothers. When
sharing of resistance proteins between siblings was sepa-
rated by individual timepoint, infant resistomes were sig-
nificantly more similar to their twin sibling’s resistome
than to the resistome of an unrelated infant (p = <0.005,
all timepoints, Additional file 1: Figure S3). The compos-
ition of infant resistomes appears generally robust in the
face of amoxicillin perturbation: neither the overall popu-
lation of resistance protein nor the specific sub-population
of β-lactamases was affected by amoxicillin exposure when
measured approximately 3 months after antibiotic
treatment. There was, however, a statistically significant
increase in the number of multidrug efflux pumpsed resistance proteins were collapsed into 97 % identity clusters. Binary
r (1) the same infant at different timepoints (self-sharing), (2) twin
mily. a All resistance proteins at left; b the subset of β-lactamases and
udent’s t-test with 1000 Monte Carlo simulations (**p < 0.01). Infant
same subject at different timepoints than to their mothers or unrelated
to unrelated infants. There was also no significant difference between
istance proteins within a given individual at different
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after amoxicillin exposure in these infants (p < 0.0001, log-
linear model, Additional file 1: Table S3).
We used a log-linear model to test the likelihood that
resistance-associated protein clusters would be shared
within multiple members of a given family, or between un-
related families (Fig. 2). Although resistance-associated
proteins were less likely to be found in more than one
family member than in just one individual (p < 0.0001,
Additional file 1: Table S4) and less likely to be found in
multiple families than in a single family (p < 0.0001,
Additional file 1: Table S4), resistance proteins that were
found in more than one individual within a family wereFig. 2 Sharing of resistance-associated proteins within and between families.
clusters, grouped by the number of members within a given family they were
of one family; much smaller numbers were identified in multiple family m
of resistance-associated protein clusters identified in multiple families, groupe
Larger proportions of resistance-associated proteins that are shared are multip
unrelated familiesalso significantly more likely to be found in more than one
family (p < 0.0001, Additional file 1: Table S4). We also
used a log-linear model to test the likelihood that
resistance-associated protein clusters that persisted within
a given individual at different timepoints were more likely
to be shared within and between families. Although resist-
ance proteins were significantly less likely to be persistent
at multiple timepoints than found at a single timepoint
(p < 0.0001, Additional file 1: Table S10), and also less
likely to be found in multiple individuals than in a sin-
gle individual (p < 0.0001, Additional file 1: Table S10),
resistance proteins that persisted within an individual
over time were also significantly more likely to beThe top graph shows absolute counts of resistance-associated protein
identified in. Most protein clusters were only identified in one member
embers or multiple families. The lower graph shows the proportions
d by the number of members of a single family they were identified in.
le members of a single family are also identified in multiple
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0.0449). There was no significant interaction between
persistence of resistance proteins within an individual
over time and sharing between unrelated families.
We used a log-linear model to test the contribution of
co-localization with a mobile genetic element to sharing
of resistance protein clusters within members of a single
family and between unrelated families. One hundred
thirty-six of 905 (15.1 %) resistance-associated protein
clusters were encoded by genes co-localized with a mo-
bile genetic element. However, this co-localization was
not significantly associated with sharing of a protein
cluster within members of a given family (p = 0.2212,
Additional file 1: Table S5) or between members of un-
related families (p = 0.2655, Additional file 1: Table S5).
β-lactam resistance was universal across the study co-
hort, yet there was substantial inter-subject variation in
the pattern of specific β-lactam resistance phenotypes
(Figs. 3 and 4 and Additional file 1: Figures S1 and S2).Fig. 3 β-lactamase phylogenetic tree. Predicted β-lactamase protein seque
sequences with at least 90 % coverage of the nearest hit in the NCBI nr da
Muscle and the tree was made using FastTree. Nodes with an S-H value >0
Class A β-lactamases separated into two groups: one with high identity to
co-localized with mobile genetic elements are marked with a gray dot. Novel
marked with a star. β-lactamases found in cefepime selections are marked witOnly 5 of 47 (10.7 %) β-lactamase family proteins were
shared between infants and mothers, similar to the pro-
portion shared with unrelated infants (4 of 47, or 8.5 %).
Consistent with trends observed in the general resis-
tome, β-lactam resistance patterns were similar between
siblings and stable over time, where 11 of 47 (23.4 %) β-
lactamases and penicillin-binding proteins were shared
with the infants’ twin sibling and 13 of 47 (27.7 %) per-
sisted within the same individual at multiple samplings.
Infant β-lactam resistomes were significantly more like
their own resistome at another timepoint or a twin sib-
ling’s resistome than the resistome of an unrelated in-
fant, and significantly more similar to their twin siblings’
than to their mothers’ resistomes (p < 0.01, Student’s t-test
with 1000 Monte Carlo simulations, Fig. 1b). When each
timepoint was analyzed separately, twin siblings’ resis-
tomes were only significantly more similar to each other
than to those of an unrelated infant of the same age at
timepoint 2 (Additional file 1: Figure S3).nces were collapsed into 97 % ID clusters. All β-lactamase protein
tabase were included in the tree. Multiple alignment was done with
.7 are marked with a square. All classes of β-lactamases are present.
TEM extended-spectrum β-lactamases and one without. β-lactamases
β-lactamases with less than 70 % identity to any known β-lactamase are
h a triangle
Fig. 4 β-lactam phylogenetic tree, annotated by study subject. Maternal subjects are marked with an “M”. Infant fecal samples are marked with a
number; “1” indicating the first (baseline) sample collected at 1–2 months of age, “2” indicating the second sample collected at 6–7 months of
age, and “3” indicating the third sample collected at 11 months of age. The antibiotic-naïve control family is colored green, the family with infants
discordant for amoxicillin exposure at 8 months of age is colored purple, and the family with infants concordant for amoxicillin exposure at 8
months of age is colored brown. Infant twin A subjects are shaded darker; twin B subjects are shaded lighter. β-lactamases were commonly present
in both members of a twin pair, and frequently persisted at more than one timepoint within a given subject. Many β-lactamases identified in the
infant fecal microbiomes were not present in the maternal microbiome
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at all timepoints. We observed distinct infantile and
adult-like populations of chloramphenicol resistance
genes. In the fecal samples collected in early infancy
(1 or 2 months, and 6 or 7 months), chloramphenicol
resistance genes primarily encoded multidrug efflux
pumps (Fig. 2). We used a log-linear model to test the
likelihood that multidrug efflux pumps were found in
mothers versus infants and that these pumps became
less common over time. Multidrug efflux pumps were
significantly more common in infants than in mothers
(p = 0.0009, Additional file 1: Table S6) and were signifi-
cantly less likely to be found as infant age increased dur-
ing the first year of life (p < 0.0001, Additional file 1:
Table S7). A majority (85 %) of these efflux pumps had
>90 % identity to efflux pumps of Enterobacteriaceae ori-
gin; only one (CL2137) was identical to a bifidobacterial
major facilitator transporter (WP_003817038). Some
multidrug efflux pumps originated from source contigs
with sequences identical to those of bona fide pathogens:
a 3737 bp contig from a 1-month-old infant (and a 1460
bp contig from the twin sibling) had 100 % sequence
identity to the recently described pan-resistant Entero-
bacter aerogenes strain EA1509E [19].
While multidrug efflux pumps were the most common
effectors of chloramphenicol resistance in stools of young
infants, chloramphenicol acetyltransferases were more fre-
quently associated with maternal resistomes. We used a
log-linear model to test the likelihood that chlorampheni-
col acetyltransferases were found in mothers versus in-
fants and that these acetyltransferases became more
common over time. Chloramphenicol acetyltransferaseswere significantly more common in mothers than infants
(p < 0.0001, Additional file 1: Table S8), were rarely found
in the youngest infants, but were found in five of the six
infants at the final (11-month) timepoint (Fig. 4). There
was, however, no significant increase over time in the like-
lihood of finding chloramphenicol acetyltransferases in
infant gut microbiomes (p = 0.2930, Additional file 1:
Table S9). Twenty-five percent of the chloramphenicol
acetyltransferases identified in this study population were
co-localized with mobile genetic elements. Novel proteins
made up more than half of the chloramphenicol acetyl-
transferases identified in this study: seven of the 12 chlor-
amphenicol acetyltransferase clusters identified had <75 %
protein identity to any known acetyltransferase. The
source contigs for these novel resistance proteins also had
low identity to any known organism.
Discussion
In this study population, we found a diverse fecal resistome
established within 1–2 months of birth. Prior microbiome
studies of twin infants have shown that siblings’ micro-
biomes undergo similar changes over time [13] and are
similar to each other irrespective of zygosity [15, 20, 21];
the patterns of sharing of resistance-associated proteins be-
tween twin siblings we observed are consistent with this
prior work on the overall microbial community, and likely
reflect similarities between siblings in microbial commu-
nity composition. We also found that infants’ gut resis-
tomes differed from those of their mothers in early life,
which is also consistent with studies showing that the gut
microbiota of twin infants are more similar to each other
than to their mothers’ microbiota [20] and that infant gut-
Moore et al. Microbiome  (2015) 3:27 Page 6 of 10associated tetracycline resistance genes [6, 7] are distinct
from those in the maternal fecal microbiota [6, 7]. The as-
sembly of a diverse gut resistome within the first 2 months
of life, and the greater resemblance of infant gut resis-
tomes to their own and their siblings’ resistomes at other
timepoints than to the resistomes of unrelated infants,
suggest that family-specific shared environmental factors
early in life shape resistome development. The dissimilar-
ity of infant resistomes to those of their mothers suggests
that, although gut microbes may be shared between the
mothers and vaginally delivered infants [22], the maternal
gut resistome is not the primary driver of gut resistome
establishment in infants. The previously observed pattern
in which twin siblings’ microbiomes are similar to each
other and dissimilar to their mothers’ microbiome also ap-
plies to the gut resistome, suggesting that the infants’ gut
resistome is likely a reflection of community composition.
In every family, phenotypic resistance to at least one
broad-spectrum β-lactam encoded by an infant gut resis-
tome was not observed in the mothers’ resistome, although
the specific antibiotics involved (piperacillin-tazobactam,Fig. 5 Populations of chloramphenicol resistance proteins change over tim
screened on chloramphenicol-containing media were collapsed into 97 %
were identified in the fecal metagenome of a study subject at a given time
not present. Proteins that were co-localized with a mobile genetic element
found in all mothers and in five of the six infants at the final timepoint, bu
contrast, multidrug efflux pumps were rare in mothers and in 11-month-olcefotaxime, aztreonam, and/or cefepime) varied (Figs. 3 and
5 and Additional file 1: Figure S1). The genetic dissimilarity
between infants’ beta-lactam resistomes and those of their
mothers likely explains this phenotypic difference, as phylo-
genetic groups of resistance genes were often associated
with specific β-lactam antibiotics. For example, one group
of class A β-lactamases with high identity to TEM β-
lactamases was associated with extended-spectrum
penicillin and β-lactamase inhibitor resistance (Fig. 3
and Additional file 1: Figure S2), while another class A
group was more closely associated with resistance to
later-generation cephalosporins. The origin of the
broader-spectrum beta-lactam resistance in infant gut
resistomes is unclear, although colonization with
antibiotic-resistant hospital bacterial strains is a possi-
bility that warrants further study (all newborn subjects
were healthy hospital-born infants). However, we wish
to note that the multidrug-resistant pathogen Escherichia
coli ST131 does not colonize the infants in this cohort
until well after discharge from the hospital [23]. The lack
of time-dependent effects on β-lactam resistance genese. Predicted proteins found when fecal metagenomic libraries were
ID clusters. Black boxes signify genes encoding a resistance protein that
point, while white or light gray squares indicate that the protein was
are marked with an asterisk. Chloramphenicol acetyltransferases were
t were qualitatively less common in infants at earlier timepoints. By
d infants, but were commonly found in earlier samples
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may reflect the sampling resolution in this small study, in
which the resistome is sampled 1 or 2 months prior to
antibiotic therapy and 3 months after antibiotic exposure.
Prior studies have shown acute antibiotic-induced pertur-
bations in adult gut microbial community concomitant
with host antibiotic exposure, followed by partial recovery
[24, 25]. The binary data regarding presence or absence of
resistance genes generated by this study also precludes de-
tection of any changes in the relative abundance of certain
taxa following antibiotic exposure. Future studies includ-
ing more frequent fecal sampling surrounding the time of
host antibiotic exposure and additional data regarding the
abundance of selected resistance genes may illuminate
more acute and transient antibiotic effects that our study
was not designed or powered to detect.
Understanding patterns of gut-associated resistance
gene dissemination within human communities has epi-
demiologic implications. We found that sharing of resist-
ance genes within families was positively associated with
sharing between families, and that persistence of resist-
ance genes within an individual over time was positively
associated with sharing with within-family sharing, but
not with between-family sharing. Co-localization with a
mobile genetic element was not significantly correlated
with identification of resistance proteins in multiple in-
dividuals. This finding may be explained by undercount-
ing mobilizable elements in this functional metagenomic
study, where nearly all contigs identified were <5 kilo-
bases (kb). This concern is partially mitigated by the
demonstration that trends in resistance gene and
mobilization element co-localization predicted by small-
insert functional metagenomics are recapitulated by
matched calculations from bacterial whole genome se-
quences [26]. Alternatively, our data may suggest that
the distribution of gut-associated resistance genes pri-
marily reflects the prevalence of specific host bacteria
within the human community, rather than any associ-
ation with mobile genetic elements, as has been demon-
strated in soil microbiomes and resistomes [26]. The
positive association between persistence within individ-
uals over time and within-family sharing but not
between-family sharing may be a reflection of host gen-
etics or shared environment shaping microbial commu-
nities; microbes that are more likely to persist within an
individual may also be more likely to colonize close rela-
tives. The potential role for examining genes shared
within families to detect clinically important resistance
genes emerging human communities warrants further
investigation.
Chloramphenicol resistance was universal in all sub-
jects at all timepoints, consistent with our previous
resistome study of single timepoint samples of unrelated
infants and children [5] as well as with prior studiesshowing highly prevalent chloramphenicol resistance in
adult populations [27]. The reason for universal chlor-
amphenicol resistance is unclear. Agricultural use of
chloramphenicol providing selection pressure (the “farm
to fork” model [27]) is a potential factor; alternatively,
chloramphenicol resistance genes may play a yet-to-be
determined role as a core functional component of the
gut microbiome [20]. Chloramphenicol resistance genes
demonstrated a developmental progression from a neo-
natal to an adult-like state. The infant chloramphenicol
resistome was initially dominated by multidrug efflux
pumps, which were uncommonly found in maternal
chloramphenicol selections, and became less common
over time. Because most of the source contigs for these
multidrug efflux pumps had high identity to Enterobac-
teriaceae, it is unlikely that the predominance of multi-
drug efflux pumps in early infancy is a result of
bifidobacteria- or lactobacilli-enriched infantile gut mi-
crobial communities. Importantly, our past studies with
adult and pediatric human microbiome samples have
demonstrated functional capture of numerous resistance
genes of Firmicutes, Bacteroidetes, and Actinobacteria
origin, without over-representation of Proteobacterial
genes [5, 28], suggesting the observed Enterobacteria-
ceae multidrug efflux pump enrichment signal is not an
artifact of cloning bias in our E. coli screening host. Prior
studies have shown that Enterobacteriaceae are enriched in
the gut microbial communities of young infants and de-
crease with time [15, 29]; the observed decrease in
chloramphenicol-resistant multidrug efflux pumps during
the first year of life in this cohort may be a reflection of
maturation of the gut microbial community. Chloram-
phenicol acetyltransferases were more commonly found in
mothers, although they were identified in all infant subjects
at some timepoint. This finding of cryptic organisms as an
important source of novel chloramphenicol resistance
genes is consistent with our prior survey of the antibiotic
resistome of healthy children [5].
Conclusions
This longitudinal study of three pairs of healthy twins
and their mothers shows that a diverse gut resistome is
present in the first 2 months of life. This confirms our
prior hypothesis that multiple antibiotic resistance is
present in very young infants [5], and underscores the
importance of future study to understand the environ-
mental determinants of resistome establishment in the
first weeks of life. Prior studies have shown that gut mi-
crobial communities and community-encoded micro-
bial functions of twin siblings are similar to each other
[13, 15, 20, 21]; our study shows that the gut resistomes
of twin pairs also remain similar to each other through-
out the first year of life, reinforcing the influence of
shared host genetic and environmental variables driving
Moore et al. Microbiome  (2015) 3:27 Page 8 of 10resistome development. Infant gut resistomes were no
more similar to those of their mothers than to unre-
lated infants, indicating that factors other than the ma-
ternal gut microbial composition are critical for
shaping the infant fecal microbiome. Recent work has
shown that microbial communities on environmental
surfaces in hospitals and homes significantly affect the
composition of host-associated microbial communities
for humans in those habitats [30, 31], and soil microbes
have also been found to have resistance genes identical
to those in human pathogens [32]. Although antibiotic-
resistant bacteria have been identified on many food
products [33–35], 1–2-month-old infants are unlikely
to have substantial solid food exposure, and thus envir-
onmental surface exposures are more likely to shape
the gut resistome of young infants. The association be-
tween resistance genes that are shared within and be-
tween families suggests a potential role for surveillance
of resistance genes within families as a first indicator of
resistance genes that are becoming prevalent in the lar-
ger community. Infants tended to have resistance to
clinically important broad-spectrum β-lactam antibi-
otics that their mothers lacked; this, in combination
with the dissimilarity between the populations of infant
and maternal β-lactamases, suggests that understanding
the factors predisposing infant microbiota to harbor these
undesirable β-lactamases may lead to better understanding
of the determinants of widespread broad-spectrum β-
lactamase resistance in human communities. Finally, we
describe a developmental progression for a potentially
core microbial function of chloramphenicol resistance,
which progresses from Enterobacteriaceae multidrug ef-
flux pumps in early infancy to an adult-like population of
chloramphenicol acetyltransferases that are often encoded
by cryptic microbes, providing new insight into the devel-
opment of microbiome functions in the early life of the
human host.
Methods
Maternal stools were collected at delivery, and infant fecal
samples were collected at 1–2 (baseline), 6–7 (30 days after
solid food initiation), and 11 months of age (post-antibiotic
exposure). All fecal samples used in this study were col-
lected with informed consent for the St. Louis Neonatal
Microbiome Initiative (P.I. Dr. Barbara Warner). This study
and the St. Louis Neonatal Microbiome Initiative were ap-
proved by Washington University’s Institutional Review
Board (IRB# 201205152 and 201105492, respectively).
Demographics and clinical metadata were securely stored
in a RedCap [36] database. The resistomes encoded by
these infant and maternal fecal samples were characterized
using functional metagenomic selections [4, 5, 32]. We
constructed metagenomic libraries by shotgun cloning
one- to five-Kb DNA fragments from the 21 fecal samples(Additional file 1: Table S1) into a pZE21 plasmid vector,
and transforming the plasmids into E. coli as previously
described [5]. These libraries were screened for resistance
against 18 antibiotics representing eight drug classes
(β-lactams, tetracyclines, aminoglycosides, amphenicols,
quinolones, sulfonamides, polymyxins, and cycloserine).
Resistance was observed to 16 of the 18 antibiotics tested
(Additional file 1: Table S2); resistance-conferring frag-
ments were sequenced, assembled, and annotated using
the Parallel Annotation and Reassembly of Functional
Metagenomic Selections (PARFuMS) iterative assembly
pipeline [32] (see online methods). Predicted proteins
were clustered at the 97 % identity level using cd-hit
[17, 18]. Resistance proteins and mobilization elements
were identified by a previously described keyword
string search of predicted proteins annotated by the
PARFuMS computational pipeline [5]. Statistical ana-
lysis was performed on these 97 % ID clusters using
SAS version 9.3. Analyses on resistance protein clusters
were performed using log-linear models assuming a
negative binomial distribution of protein cluster counts.
Tables of pairwise sample similarity between all sam-
ples were calculated using the binary Jaccard distance
metric from the QIIME package [37].
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